The intranasal drug delivery devices market involves devices that deliver drugs to the nasal cavity to provide local treatment or enter circulation. Some of the key advantages of intranasal drug delivery include rapid absorption of drugs into systemic circulation due to superior vascularization, avoidance of first-pass metabolism through the liver which helps in improved bioavailability, and instant onset of action. These advantages have led to the increased use of intranasal delivery of drugs to treat conditions like migraine, pain management, allergies and nasal congestion.
The Global intranasal drug delivery devices market is estimated to be valued at US$ 3.27 Bn in 2024 and is expected to exhibit a CAGR of 13.% over the forecast period from 2024 to 2031.
Key Takeaways
Key players operating in the intranasal drug delivery devices are GlaxoSmithKline PLC, AstraZeneca PLC, copyright, Inc., OptiNose, Inc., 3M Company, Becton, Dickinson and Company, Promius Pharma, LLC, Cadila Pharmaceuticals Ltd., B.F. Ascher & Company, Inc., PendoPharm, Inc., Douglas Pharmaceuticals Ltd., ENT Technologies Pty. Ltd., NAVEH Pharma Ltd., Novartis AG, Neurelis, Inc., Aptargroup, Inc. The key players are focusing on developing advanced devices to improve drug delivery and expand their product offerings.
The key opportunities in the Intranasal Drug Delivery Devices Market Size include development of user-friendly devices, combination products with drugs, and targeting new therapeutic applications. Emerging markets such as Asia Pacific and Middle East are expected to provide lucrative growth opportunities for players due to increasing healthcare spending and demand for non-invasive drug delivery solutions.
The global expansion of the intranasal drug delivery devices market is driven by increasing R&D activities for nasal formulations by pharmaceutical companies. Regions with high nasal drug delivery acceptance like North America and Europe dominate the market currently but other regions are also witnessing faster adoption.
Market drivers: The major driver boosting growth of intranasal drug delivery devices market is the increasing preference for non-invasive drug delivery routes over invasive methods. Nasal drug delivery provides direct access to brain and systemic circulation without passing through gastrointestinal tract and liver, enabling faster therapeutic effect. Rising incidence of neurological disorders and allergies are also contributing to the demand for intranasal drugs and associated devices for improved treatment outcomes.
PEST Analysis
Political: Regulation around drug delivery devices development & manufacturing in various regions is continuously evolving. Local governments are actively promoting healthcare sector growth.
Economic: Rising income levels globally expanding accessibility to advanced drug delivery solutions. However, macroeconomic volatility and currency fluctuations pose risks.
Social: Increasing awareness about benefits of non-invasive delivery raising preference for intranasal administration over injections. Aging populations drive demand for easy to use products.
Technological: Continuous R&D in materials and mechanisms enhancing precision and efficiency. Miniaturization and digital technologies widening scope of conditions addressable. Connected devices enable remote monitoring.
The North American and European markets currently account for over 65% of the global intranasal drug delivery devices market value due to advanced healthcare infrastructure and high adoption of new treatment options. The United States represents the single largest market.
The Asia Pacific region presents tremendous growth opportunities propelled by rising healthcare expenditures, huge patient pools and increasing focus of global players. China, India and other Southeast Asian countries are poised to become major production and consumption hubs in the coming years supported by favorable policy support and industrialization.
Get More Insights on- Intranasal Drug Delivery Devices Market
For Deeper Insights, Find the Report in the Language that You want:
About Author:
Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights.
(LinkedIn: www.linkedin.com/in/alice-mutum-3b247b137 )